A veteran statistician explains why she’s unconvinced digital twins can replace randomization in clinical trials, at least for now.
- What Will Life Science Orgs Do When The AI Bill Comes Through?
- Clinical Trial Standards — What They Are And Why They're Indispensable
- The Data Was Already There: RWE's Real Bottleneck Is People
- Two Planning Mistakes That Quietly Sink Clinical Programs
- Duplicate Tech, Not Technology, Is Burning Out Trial Sites
- The Real Reason Clinical Trial Systems Don't Talk To Each Other
- The Vendor Questions Most Clinical Tech Buyers Forget To Ask
- AI In Clinical Trials: Stop Hyping It, Start Proving It
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
CAR T Study For Blockbuster Drug Granted Therapy Designation
Discover how a pharmaceutical sponsor received support for an EDC and IRT database build and got help with data management and biostatistics.
-
Why eSource Ensures Data Integrity In Medical Device Clinical Trials
Learn how eSource data capture offers a more efficient and cost-effective approach to maintaining data integrity.
-
Navigating The Post-Capture Era Of Clinical Trials
Liberating data through structured workflow management is the key to evolving clinical trials from a series of administrative hurdles into a high-speed engine for medical innovation.
-
Pharmaceutical Company Gets Unified Decentralized Platform
Unearth how this global eClinical provider delivered a decentralized platform including eSource/ePRO for direct-data-entry, randomization, eConsent, telehealth, remote monitoring, and data management.
-
FDA Pushes For Patient Voice: ePRO In Oncology Trials
FDA urges sponsors and CROs to include patient voices in oncology trials. Discover why it matters and how to start integrating this approach.
-
Simplify Clinical Trials With Signant SmartSignals® Unified Platform
Signant SmartSignals® Unified Platform streamlines clinical trials by integrating eConsent, data collection, remote consultations, and randomization, simplifying workflows for patients and site staff.
-
Do We Still Need Patients In Tomorrow's Trials?
Delve into how advanced technologies reshape drug development and patient care, and the crucial balance needed between innovation and ethical responsibility to achieve better trial outcomes.
-
Customizing EDC Workflows For Specialty Pharma, Rare Disease Trials
Rare disease and specialty pharma trials demand a level of flexibility with electronic data capture systems that can adapt dynamically without sacrificing data integrity.
-
The Future Of Data Linkage In Clinical Trial Evidence Generation
Explore key questions about the future of AI and data linkage in clinical trial evidence generation.
-
Future Predictions For Clinical Technologies
In 2025, sponsors are prioritizing configurable, interoperable solutions that integrate seamlessly across IRT, eCOA, CTMS, eConsent, and supply chain systems.
RECENT NEWSLETTERS
- 09.10.26 -- AI, Trial Costs, And RTSM Are Reshaping Clinical Operations
- 09.05.26 -- Best Of August: AI, FDA RWE, And Trial Data Risks
- 09.03.26 -- AI, APIs, and eConsent Are Exposing Trial Workflow Gaps
- 08.27.26 -- Patient Data Breaks Down When Trial Systems Miss Reality
- 08.20.26 -- Clinical AI Validation, Trial Handoffs, And Smarter Study Builds